ArticleBiochemical pharmacology2011

The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.

Noemi Kedei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.